Skip to main content
Fig. 1 | Biomaterials Research

Fig. 1

From: A drug delivery system constructed by a fusion peptide capturing exosomes targets to titanium implants accurately resulting the enhancement of osseointegration peri-implant

Fig. 1

PEP bonded and targeted to the titanium surface specifically. A CLSM imaged PEP1–3 bonded on the Ti and non-Ti discs. B QCM measures the binding of PEP1–3 on Ti surfaces. Shift in frequency(∆f) versus time for exposure of the Ti sensor to PEP1–3 (100 μg/ml). At the time points indicated by the arrows, peptide solutions or phosphate buffered saline (PBS) were injected. C AFM images of PEP1–3 adsorbed on Ti surfaces. D XPS analysis of (a) total spectrum, (b) O 1 s and (c) N 1 s spectra evaluation of titanium surfaces treated with PEP1-3. E IVIS showed the distribution of AF680-labeled PEP1–3 in vivo

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us